NCT03937661View on ClinicalTrials.gov

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

January 30, 2025

Study Completion Date

August 30, 2025

Conditions
Ovary; AnomalyInfertility, Female
Interventions
BIOLOGICAL

PRP

Autologous PRP intra ovarian infusion

BIOLOGICAL

Placebo

Autologous PFP intra ovarian infusion

Trial Locations (1)

15232

RECRUITING

Genesis AC, Athens

All Listed Sponsors
collaborator

National and Kapodistrian University of Athens

OTHER

lead

Genesis Athens Clinic

OTHER